ERBB2 and breast cancer: This cytotoxicity was corroborated by molecular docking studies, which identified strong binding of GST compounds to breast cancer proteins HER1 and HER2, with Gymnemic acid XIII and Gymnemic acid V exhibiting the highest binding energies.